In the analysis of IL-36γ serum levels in patients with benign ovarian tumor (reference group) vs. patients with ovarian cancer (study group), an increase in IL-36γ levels was noted in the ovarian cancer group. The gene discussed is IL36G; the disease is ovarian benign neoplasm.